Hawaii 2023 Regular Session

Hawaii Senate Bill SB1395 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	THE SENATE S.B. NO. 1395 THIRTY-SECOND LEGISLATURE, 2023 STATE OF HAWAII A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
2	2
3	3	THE SENATE S.B. NO. 1395
4	4	THIRTY-SECOND LEGISLATURE, 2023
5	5	STATE OF HAWAII
6	6
7	7	THE SENATE
8	8
9	9	S.B. NO.
10	10
11	11	1395
12	12
13	13	THIRTY-SECOND LEGISLATURE, 2023
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29
30	30
31	31	A BILL FOR AN ACT
32	32
33	33
34	34
35	35
36	36
37	37	RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
38	38
39	39
40	40
41	41
42	42
43	43	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
44	44
45	45
46	46
47	47	SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows: 1. By amending subsection (b) to read as follows: "(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and geometric isomers, salts, and salts of isomers; (4) Acryl fentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name: acryloylfentanyl); (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide); (6) Allylprodine; (7) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM); (8) Alphameprodine; (9) Alphamethadol; (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine); (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (12) Benzethidine; (13) Benzylfentanyl (N-[1-benzyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers; (14) Betacetylmethadol; (15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); (16) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide); (17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide); (18) Betameprodine; (19) Betamethadol; (20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name: [beta]-methyl fentanyl); (21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names: [beta]'-phenyl fentanyl; 3-phenylpropanoyl fentanyl); (22) Betaprodine; (23) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); (24) Clonitazene; (25) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide); (26) Dextromoramide; (27) Diampromide; (28) Diethylthiambutene; (29) Difenoxin; (30) Dimenoxadol; (31) Dimepheptanol; (32) Dimethylthiambutene; (33) Dioxaphetyl butyrate; (34) Dipipanone; (35) Ethylmethylthiambutene; (36) Etonitazene; (37) Etoxeridine; (38) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate); (39) 4-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other name: para-fluoroisobutyryl fentanyl); (40) 2'-fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other name: 2'-fluoro 2-fluorofentanyl); (41) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide); (42) Furethidine; (43) Hydroxypethidine; (44) Ketobemidone; (45) Levomoramide; (46) Levophenacylmorphan; (47) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (48) 4'-methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide); (49) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); (50) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (51) Morpheridine; (52) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); (53) Noracymethadol; (54) Norlevorphanol; (55) Normethadone; (56) Norpipanone; (57) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide]; (58) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide); (59) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name: 2-fluorobutyryl fentanyl); (60) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl); (61) Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); (62) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl acetylfentanyl); (63) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl methoxyacetyl fentanyl); (64) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); (65) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide; (66) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide); (67) Para-methylfentanyl (N-(4-methylphenyl)-N(1-phenethylpiperidin-4-yl)propionamide) (Other name: 4-methylfentanyl); (68) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine); (69) Phenadoxone; (70) Phenampromide; (71) Phenomorphan; (72) Phenoperidine; (73) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other name: benzoyl fentanyl); (74) Piritramide; (75) Proheptazine; (76) Properidine; (77) Propiram; (78) Racemoramide; (79) Thenylfentanyl (N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers; (80) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide); (81) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other names: 2-thiofuranyl fentanyl; thiophene fentanyl); (82) Tilidine; (83) Trimeperidine; [and] (84) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)[.]; and (85) 2-(ethylamino)-2-(3-methoxylphenyl)cyclohexan-1-one(methoxetamine, MXE), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation." 2. By amending subsection (e) to read as follows: "(e) Depressants. Unless specifically excepted, the schedule shall include any material, compound, mixture, or preparation which contains any quantity of the substance: (1) Mecloqualone; (2) Methaqualone; (3) Etizolam (including its optical, positional, and geometric isomers, salts, and salts of isomers, where possible); [or] (4) Flualprazolam (including its optical, positional, and geometric isomers, salts, and salts of isomers, where possible)[.]; (5) N-ethylhexedrone (Other names: aethylaminohexanophenone, 2-(ethylamino)-1-phenylhexan-s1-one); (6) alpha-pyrrolidinohexanophenone (Other names: a-PHP, apyrrolidinohexanophenone, 1-phenyl-2-(pyrrolidine-1-yl)hexan-1-one); (7) 4-methyl-alphaethylaminopentiophenone (Other names: 4-MEAP, 2-(ethylamino)-1-(4-methylphyl)pentan-1-one); (8) 4'-methyl-alphapyrrolidinohexiophenone (Other names: MPHP, 4'-methyl-alphapyrrolidinohexanophenone, 1-(4-methylphenyl)-2-(pyrrolidine-1-yl)hexan1-one); (9) Alpha-pyrrolidinoheptaphenone (Other names: PV8, 1-phenyl-2-(pyrrolidine-1-yl)heptan-1-one); and (10) 4'chloro-alphapyrrolidinovalerophenone (Other names: 4-chloro-a-PVP, 4'-chloro-apyrrolidinopentiophenone, 1-(4-chlorophenyl)-2-(pyrrolidine-1-yl)pentan-1-one) including their optical, positional, and geometric isomers, salts, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation." 3. By amending subsection (f) to read as follows: "(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Aminorex; (2) Cathinone; (3) 4,4'-dimethylaminorex (common name: 4,4'-DMAR); (4) Fenethylline; (5) Methcathinone; (6) 4-methylaminorex; (7) N-ethylamphetamine; (8) N,N-dimethylamphetamine; (9) Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: (A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; (B) By substitution at the 3-position with an acyclic alkyl substituent; or (C) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. Some other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine, 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible; and (10) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (Other names: para-methoxymethamphetamine; PMMA)[.]; (11) Ethyl 2-(1-(5-fluoropentyl)-1Hindazole-3-carboxamido)-3,3-demethylbutanoate (Other name: 5FEDMB-PINACA); (12) Methyl 2-(1-(5-fluropentyl)-1Hindole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5FMDMB-PICA; 5F-MDMB-2201); (13) N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-fluorobenzyl)); (14) 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 5F-CUMYLPINACA; SGT-25); and (15) (1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (Other name: FUB-144) including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation." SECTION 2. Section 329-20, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows: "(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Lorcaserin; (6) Mazindol; (7) Mefenorex; (8) Modafinil; (9) Pemoline (including organometallic complexes and chelates thereof); (10) Phentermine; (11) Pipradrol; (12) Serdexmethylphenidate; (13) Sibutramine; (14) Solriamfetol; [and] (15) SPA (1-dimethylamino-1,2-dephenylethane, lefetamine)[.]; (16) Serdexmethylphenidate, including its salts, isomers, and salts of isomers; and (17) Daridorexant and its salts." SECTION 3. Section 329-22, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows: "(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts; (2) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide], (Vimpat); (3) Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide); [and] (4) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid][.]; and (5) Ganaxolone and its salts." SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored. SECTION 6. This Act shall take effect upon its approval. INTRODUCED BY: _____________________________ BY REQUEST
48	48
49	49	SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows:
50	50
51	51	1. By amending subsection (b) to read as follows:
52	52
53	53	"(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
54	54
55	55	(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
56	56
57	57	(2) Acetylmethadol;
58	58
59	59	(3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and geometric isomers, salts, and salts of isomers;
60	60
61	61	(4) Acryl fentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name: acryloylfentanyl);
62	62
63	63	(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);
64	64
65	65	(6) Allylprodine;
66	66
67	67	(7) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM);
68	68
69	69	(8) Alphameprodine;
70	70
71	71	(9) Alphamethadol;
72	72
73	73	(10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);
74	74
75	75	(11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
76	76
77	77	(12) Benzethidine;
78	78
79	79	(13) Benzylfentanyl (N-[1-benzyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers;
80	80
81	81	(14) Betacetylmethadol;
82	82
83	83	(15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
84	84
85	85	(16) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
86	86
87	87	(17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);
88	88
89	89	(18) Betameprodine;
90	90
91	91	(19) Betamethadol;
92	92
93	93	(20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name: [beta]-methyl fentanyl);
94	94
95	95	(21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names: [beta]'-phenyl fentanyl; 3-phenylpropanoyl fentanyl);
96	96
97	97	(22) Betaprodine;
98	98
99	99	(23) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);
100	100
101	101	(24) Clonitazene;
102	102
103	103	(25) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
104	104
105	105	(26) Dextromoramide;
106	106
107	107	(27) Diampromide;
108	108
109	109	(28) Diethylthiambutene;
110	110
111	111	(29) Difenoxin;
112	112
113	113	(30) Dimenoxadol;
114	114
115	115	(31) Dimepheptanol;
116	116
117	117	(32) Dimethylthiambutene;
118	118
119	119	(33) Dioxaphetyl butyrate;
120	120
121	121	(34) Dipipanone;
122	122
123	123	(35) Ethylmethylthiambutene;
124	124
125	125	(36) Etonitazene;
126	126
127	127	(37) Etoxeridine;
128	128
129	129	(38) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate);
130	130
131	131	(39) 4-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other name: para-fluoroisobutyryl fentanyl);
132	132
133	133	(40) 2'-fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other name: 2'-fluoro 2-fluorofentanyl);
134	134
135	135	(41) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide);
136	136
137	137	(42) Furethidine;
138	138
139	139	(43) Hydroxypethidine;
140	140
141	141	(44) Ketobemidone;
142	142
143	143	(45) Levomoramide;
144	144
145	145	(46) Levophenacylmorphan;
146	146
147	147	(47) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
148	148
149	149	(48) 4'-methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);
150	150
151	151	(49) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
152	152
153	153	(50) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
154	154
155	155	(51) Morpheridine;
156	156
157	157	(52) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
158	158
159	159	(53) Noracymethadol;
160	160
161	161	(54) Norlevorphanol;
162	162
163	163	(55) Normethadone;
164	164
165	165	(56) Norpipanone;
166	166
167	167	(57) Ocfentanil [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide];
168	168
169	169	(58) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);
170	170
171	171	(59) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name: 2-fluorobutyryl fentanyl);
172	172
173	173	(60) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name: 2-fluorofentanyl);
174	174
175	175	(61) Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
176	176
177	177	(62) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl acetylfentanyl);
178	178
179	179	(63) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl methoxyacetyl fentanyl);
180	180
181	181	(64) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
182	182
183	183	(65) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide;
184	184
185	185	(66) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
186	186
187	187	(67) Para-methylfentanyl (N-(4-methylphenyl)-N(1-phenethylpiperidin-4-yl)propionamide) (Other name: 4-methylfentanyl);
188	188
189	189	(68) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
190	190
191	191	(69) Phenadoxone;
192	192
193	193	(70) Phenampromide;
194	194
195	195	(71) Phenomorphan;
196	196
197	197	(72) Phenoperidine;
198	198
199	199	(73) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other name: benzoyl fentanyl);
200	200
201	201	(74) Piritramide;
202	202
203	203	(75) Proheptazine;
204	204
205	205	(76) Properidine;
206	206
207	207	(77) Propiram;
208	208
209	209	(78) Racemoramide;
210	210
211	211	(79) Thenylfentanyl (N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and salts of isomers;
212	212
213	213	(80) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
214	214
215	215	(81) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other names: 2-thiofuranyl fentanyl; thiophene fentanyl);
216	216
217	217	(82) Tilidine;
218	218
219	219	(83) Trimeperidine; [and]
220	220
221	221	(84) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)[.]; and
222	222
223	223	(85) 2-(ethylamino)-2-(3-methoxylphenyl)cyclohexan-1-one(methoxetamine, MXE), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation."
224	224
225	225	2. By amending subsection (e) to read as follows:
226	226
227	227	"(e) Depressants. Unless specifically excepted, the schedule shall include any material, compound, mixture, or preparation which contains any quantity of the substance:
228	228
229	229	(1) Mecloqualone;
230	230
231	231	(2) Methaqualone;
232	232
233	233	(3) Etizolam (including its optical, positional, and geometric isomers, salts, and salts of isomers, where possible); [or]
234	234
235	235	(4) Flualprazolam (including its optical, positional, and geometric isomers, salts, and salts of isomers, where possible)[.];
236	236
237	237	(5) N-ethylhexedrone (Other names: aethylaminohexanophenone, 2-(ethylamino)-1-phenylhexan-s1-one);
238	238
239	239	(6) alpha-pyrrolidinohexanophenone (Other names: a-PHP, apyrrolidinohexanophenone, 1-phenyl-2-(pyrrolidine-1-yl)hexan-1-one);
240	240
241	241	(7) 4-methyl-alphaethylaminopentiophenone (Other names: 4-MEAP, 2-(ethylamino)-1-(4-methylphyl)pentan-1-one);
242	242
243	243	(8) 4'-methyl-alphapyrrolidinohexiophenone (Other names: MPHP, 4'-methyl-alphapyrrolidinohexanophenone, 1-(4-methylphenyl)-2-(pyrrolidine-1-yl)hexan1-one);
244	244
245	245	(9) Alpha-pyrrolidinoheptaphenone (Other names: PV8, 1-phenyl-2-(pyrrolidine-1-yl)heptan-1-one); and
246	246
247	247	(10) 4'chloro-alphapyrrolidinovalerophenone (Other names: 4-chloro-a-PVP, 4'-chloro-apyrrolidinopentiophenone, 1-(4-chlorophenyl)-2-(pyrrolidine-1-yl)pentan-1-one) including their optical, positional, and geometric isomers, salts, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation."
248	248
249	249	3. By amending subsection (f) to read as follows:
250	250
251	251	"(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
252	252
253	253	(1) Aminorex;
254	254
255	255	(2) Cathinone;
256	256
257	257	(3) 4,4'-dimethylaminorex (common name: 4,4'-DMAR);
258	258
259	259	(4) Fenethylline;
260	260
261	261	(5) Methcathinone;
262	262
263	263	(6) 4-methylaminorex;
264	264
265	265	(7) N-ethylamphetamine;
266	266
267	267	(8) N,N-dimethylamphetamine;
268	268
269	269	(9) Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways:
270	270
271	271	(A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
272	272
273	273	(B) By substitution at the 3-position with an acyclic alkyl substituent; or
274	274
275	275	(C) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.
276	276
277	277	Some other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine, 4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP); alpha-pyrrolidinopentiophenone ([alpha]-PVP); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e); 2-(methylamino)-1-phenylpentan-1-one (pentedrone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP); 4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone (3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone); alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and geometric isomers, salts and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible; and
278	278
279	279	(10) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (Other names: para-methoxymethamphetamine; PMMA)[.];
280	280
281	281	(11) Ethyl 2-(1-(5-fluoropentyl)-1Hindazole-3-carboxamido)-3,3-demethylbutanoate (Other name: 5FEDMB-PINACA);
282	282
283	283	(12) Methyl 2-(1-(5-fluropentyl)-1Hindole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5FMDMB-PICA; 5F-MDMB-2201);
284	284
285	285	(13) N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-fluorobenzyl));
286	286
287	287	(14) 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 5F-CUMYLPINACA; SGT-25); and
288	288
289	289	(15) (1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (Other name: FUB-144) including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation."
290	290
291	291	SECTION 2. Section 329-20, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows:
292	292
293	293	"(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
294	294
295	295	(1) Cathine ((+)-norpseudoephedrine);
296	296
297	297	(2) Diethylpropion;
298	298
299	299	(3) Fencamfamin;
300	300
301	301	(4) Fenproporex;
302	302
303	303	(5) Lorcaserin;
304	304
305	305	(6) Mazindol;
306	306
307	307	(7) Mefenorex;
308	308
309	309	(8) Modafinil;
310	310
311	311	(9) Pemoline (including organometallic complexes and chelates thereof);
312	312
313	313	(10) Phentermine;
314	314
315	315	(11) Pipradrol;
316	316
317	317	(12) Serdexmethylphenidate;
318	318
319	319	(13) Sibutramine;
320	320
321	321	(14) Solriamfetol; [and]
322	322
323	323	(15) SPA (1-dimethylamino-1,2-dephenylethane, lefetamine)[.];
324	324
325	325	(16) Serdexmethylphenidate, including its salts, isomers, and salts of isomers; and
326	326
327	327	(17) Daridorexant and its salts."
328	328
329	329	SECTION 3. Section 329-22, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows:
330	330
331	331	"(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation [which] that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:
332	332
333	333	(1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (Other names: BRV; UCB-34714; Briviact) and its salts;
334	334
335	335	(2) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide], (Vimpat);
336	336
337	337	(3) Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide); [and]
338	338
339	339	(4) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid][.]; and
340	340
341	341	(5) Ganaxolone and its salts."
342	342
343	343	SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
344	344
345	345	SECTION 6. This Act shall take effect upon its approval.
346	346
347	347
348	348
349	349	INTRODUCED BY: _____________________________
350	350	BY REQUEST
351	351
352	352	INTRODUCED BY:
353	353
354	354	_____________________________
355	355
356	356
357	357
358	358
359	359
360	360	BY REQUEST
361	361
362	362	Report Title: Uniform Controlled Substances Act Description: Updates the Uniform Controlled Substances Act, chapter 329, Hawaii Revised Statutes, to make it consistent with amendments in the federal controlled substances law as required by section 329-11, Hawaii Revised Statutes. The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
363	363
364	364
365	365
366	366
367	367
368	368	Report Title:
369	369
370	370	Uniform Controlled Substances Act
371	371
372	372
373	373
374	374	Description:
375	375
376	376	Updates the Uniform Controlled Substances Act, chapter 329, Hawaii Revised Statutes, to make it consistent with amendments in the federal controlled substances law as required by section 329-11, Hawaii Revised Statutes.
377	377
378	378
379	379
380	380
381	381
382	382
383	383
384	384	The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.